156 Cash flow in FS Add: Net finance costs 60 59 68 Statement of income/ Cash flows in FS Less: Share of (profit)/loss from JV (1) (1) (0) Statement of income in FS Add: NCI 17 9 (1) Statement of income
facilities in the amount of 2.5 billion baht from Government Saving Bank in Thailand. This is not only potentially decreases our funding costs but also stabilized company financial conditions. 2 Summary of
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
) (98.65) 23.42 (122.07) (521.24) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (521.23) Net Profit The company and subsidiaries realized net profit (loss) of the 1st quarter ended as of March 31
Wudhiprecha as an Independent Director and a member the Audit Committee, effective from 14 November 2018 onwards. December Increased share capital and allocated 597.0mn newly issued ordinary shares of the
Services 2,060,114 2,473,795 -17% 1,640,996 1,631,566 1% Costs of Sales and Services (1,431,003) (2,029,194) -29% (1,057,056) (1,071,607) -1% Gross profit 629,111 444,601 42% 583,940 559,959 4% Interest
costs as our fuel expenses have increased in recent months in line with the general trends on the solid fuel market. The operational efficiency improvement projects will along with fixed cost discipline
% Finance cost -5.95 -0.92 5.03 548% Income tax expenses -2.67 -0.94 1.73 185% Net income for period 13.66 10.49 3.17 30% Earnings per share (THB) 0.05 0.03 0.02 59% FY 2018 FY 2017 YoY change YoY % change
Company, therefore, the interesting bearing debt to equity ratio and the debt to equity ratio of shareholders do not exceed 1:1 which is in compliance with the Company’s policy. The financial costs are also
49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34